Correlations of high-sensitivity C-reactive protein and atherosclerosis in Japanese type 2 diabetic patients

被引:13
作者
Anan, Futoshi
Masaki, Takayuki
Umeno, Yoshikazu
Iwao, Tetsu
Yonemochi, Hidetoshi
Eshima, Nobuoki
Saikawa, Tetsunori
Yoshimatsu, Hironobu
机构
[1] Oita Red Cross Hosp, Dept Cardiol, Oita 8700033, Japan
[2] Oita Red Cross Hosp, Dept Endocrinol, Oita 8700033, Japan
[3] Oita Univ, Sch Med, Dept Internal Med 1, Oita 87011, Japan
[4] Oita Univ, Sch Med, Dept Cardiovasc Sci, Oita 87011, Japan
[5] Oita Univ, Sch Med, Dept Biostat, Oita 87011, Japan
关键词
D O I
10.1530/EJE-07-0388
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The elevated level of high-sensitivity C-reactive protein (HSCRP) and aortic stiffness Eire associated with high mortality in type 2 diabetic patients. We tested the hypothesis that the HSCRP correlates with aortic stiffness and insulin resistance in type 2 diabetic patients. Material and methods: The study consisted of 46 Japanese patients with type 2 diabetes and high HSCRP group (0.3-1.0 mg/dl, age: 57 +/- 5 years. mean +/- S.D) and a control group of 5 5 age-matched patients with low HSCRP group (< 0.3 mg/dl, 57 +/- 6 years). Brachiat-ankle pulse wave velocity (BaPWV) was measured by automatic oscillometric method and was used as an index of atherosclerosis. Results: The body mass index (BMI) values (P < 0.05) and waist circumferences (P < 0.0005) and the waist-to-hip ratios (P < 0.05),were higher in the high HSCRP group than in the low HSCRP group. The BaPWV was higher in the high HSCRP group than in the low HSCRP group (P < 0.0001). Fasting plasma glucose (FPG; P < 0.005) and insulin concentrations (P < 0.0001), and the homeostasis model assessment (HOMA) index (P < 0.0001.), were higher in the high HSCRP group than in the low HSCRP group. Multiple regression analysis showed that HSCRP levels were independently predicted by BaPWV and HOMA index. Conclusions: Our results indicate that the elevated level of HSCRP in Japanese patients with type 2 diabetes is characterized by increased aortic stiffness and insulin resistance, and that the BaPWV and HOMA index are independent predictors of HSCRP.
引用
收藏
页码:311 / 317
页数:7
相关论文
共 46 条
[1]   Effect of statin therapy on C-reactive protein levels - The Pravastatin Inflammation/CRP Evaluation (PRINCE): A randomized trial and cohort study [J].
Albert, MA ;
Danielson, E ;
Rifai, N ;
Ridker, PM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (01) :64-70
[2]   Effects of valsartan and perindopril combination therapy on left ventricular hypertrophy and aortic arterial stiffness in patients with essential hypertension [J].
Anan, F ;
Takahashi, N ;
Ooie, T ;
Yufu, K ;
Hara, M ;
Nakagawa, M ;
Yonemochi, H ;
Saikawa, T ;
Yoshimatsu, H .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 61 (5-6) :353-359
[3]   High-sensitivity C-reactive protein is associated with insulin resistance and cardiovascular autonomic dysfunction in type 2 diabetic patients [J].
Anan, F ;
Takahashi, N ;
Nakagawa, M ;
Ooie, T ;
Saikawa, T ;
Yoshimatsu, H .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2005, 54 (04) :552-558
[4]   Inflammation and endothelial function - Direct vascular effects of human C-reactive protein on nitric oxide bioavailability [J].
Clapp, BR ;
Hirschfield, GM ;
Storry, C ;
Gallimore, JR ;
Stidwill, RP ;
Singer, M ;
Deanfield, JE ;
MacAllister, RJ ;
Pepys, MB ;
Vallance, P ;
Hingorani, AD .
CIRCULATION, 2005, 111 (12) :1530-1536
[5]   INSULIN RESISTANCE - A MULTIFACETED SYNDROME RESPONSIBLE FOR NIDDM, OBESITY, HYPERTENSION, DYSLIPIDEMIA, AND ATHEROSCLEROTIC CARDIOVASCULAR-DISEASE [J].
DEFRONZO, RA ;
FERRANNINI, E .
DIABETES CARE, 1991, 14 (03) :173-194
[6]   Chronic subclinical inflammation as part of the insulin resistance syndrome -: The Insulin Resistance Atherosclerosis Study (IRAS) [J].
Festa, A ;
D'Agostino, R ;
Howard, G ;
Mykkänen, L ;
Tracy, RP ;
Haffner, SM .
CIRCULATION, 2000, 102 (01) :42-47
[7]   Association between C-reactive protein and features of the metabolic syndrome -: A population-based study [J].
Fröhlich, M ;
Imhof, A ;
Berg, G ;
Hutchinson, WL ;
Pepys, MB ;
Boeing, H ;
Muche, R ;
Brenner, H ;
Koenig, W .
DIABETES CARE, 2000, 23 (12) :1835-1839
[8]   Issues in hypertension: Drug tolerability and special populations [J].
Gavras, HP .
AMERICAN JOURNAL OF HYPERTENSION, 2001, 14 (07) :231S-236S
[9]   ANGIOTENSIN-II STIMULATES NADH AND NADPH OXIDASE ACTIVITY IN CULTURED VASCULAR SMOOTH-MUSCLE CELLS [J].
GRIENDLING, KK ;
MINIERI, CA ;
OLLERENSHAW, JD ;
ALEXANDER, RW .
CIRCULATION RESEARCH, 1994, 74 (06) :1141-1148
[10]   Acute effects of nitric oxide blockade with L-NAME on arterial haemodynamics in the rat [J].
Hu, CT ;
Chang, KC ;
Wu, CY ;
Chen, HI .
BRITISH JOURNAL OF PHARMACOLOGY, 1997, 122 (06) :1237-1243